Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X
Analysis

A new ERA for pulmonary arterial hypertension patients in England

The NHS’s approval of Opsumit, a new drug for pulmonary arterial hypertension (PAH), marks a new era for the treatment of this rare and ultimately fatal disease. Elly Earls speaks to Actelion’s Robin Bhattacherjee and consultant physician Dr Luke Howard to find out why.

Download our 2018 Technology, Media & Telecoms Predictions worth over $5,000 for free

Close
Close
Close

Go Top